Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 2924
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00989235 | Substudy - Low Dose of Abatacept in Subjects With Rheumatoid Arthritis | ||
| NCT01195662 | A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication | ||
| NCT02460068 | A Study of Fotemustine(FTM) Vs FTM and Ipilimumab (IPI) or IPI and Nivolumab in Melanoma Brain Metastasis | ||
| NCT03500562 | Study of Daclatasvir-based Therapy in Chinese Participants With Chronic Hepatitis C (CHC) | ||
| NCT00149591 | The Viability-Guided Angioplasty After Acute Myocardial Infarction-Trial (The VIAMI-Trial) | ||
| NCT03620123 | A Randomized Phase II Study on the Optimization of Immunotherapy in Squamous Carcinoma of the Head and Neck | ||
| NCT00001024 | The Effects of Anti-HIV Drugs in HIV-Infected Patients Who Do Not Have AIDS | ||
| NCT05643170 | An Open-label Study to Assess the Long-term Safety, Tolerability, Effectiveness, and Durability of Effect of KarXT in Patients With DSM-5 Diagnosis of Schizophrenia | ||
| NCT04477642 | Abatacept for Patients With COVID-19 and Respiratory Distress | ||
| NCT00162123 | A Companion Study for Patients Enrolled in Prior/Parent Ipilimumab Studies | ||
| NCT00284180 | Vinflunine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2 (HER2neu) Over-Expressing Metastatic Breast Cancer | ||
| NCT06408259 | Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis | ||
| NCT03522246 | A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy | ||
| NCT00063388 | Phase II Study in Patients With Recurrent Non-Small-Cell Lung Cancer | ||
| NCT01003990 | Roll-Over Protocol To Provide Atv And/Or Truvada For Extended Access | ||
| NCT01471223 | Belatacept in Renal Transplantation: Analyses Using Data From the Collaborative Transplant Study | ||
| NCT01762462 | Open Label Pharmacokinetic Study of SAR302503 in Subjects With Hepatic Impairment | ||
| NCT02736123 | Neoadjuvant Combination Biotherapy With Ipilimumab and Nivolumab or Nivolumab Alone | ||
| NCT00533897 | Phase IIIB Subcutaneous Missed Dose Study | ||
| NCT02913313 | A Study of BMS-986207 Given Alone and in Combination With Nivolumab or With Nivolumab and Ipilimumab in Advanced Solid Tumors | ||
| NCT01454479 | A Phase I Study of Lapatinib (Tykerb) Plus Ixabepilone (Ixempra) as 2nd-line Treatment for Patients With HER-2 Overexpressed Recurrent or Persistent Endometrial Carcinoma or Carcinosarcoma | ||
| NCT02942407 | Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation | ||
| NCT02768558 | Cisplatin and Etoposide Plus Radiation Followed By Nivolumab/Placebo For Locally Advanced NSCLC | ||
| NCT02754726 | Combination Therapy for Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma | ||
| NCT03486899 | A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis | ||
| NCT03843658 | Identifying Novel Biomarkers in Early Rheumatology Patients | ||
| NCT07018752 | A Platform Trial Evaluating New Drugs or Combination in R/R Peripheral T-cell Lymphomas | ||
| NCT02281058 | Open-label Pilot Study of Abatacept for the Treatment of Vitiligo | ||
| NCT00231348 | Nefazodone in the Treatment of Social Phobia | ||
| NCT00389155 | First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy | ||
| NCT04200963 | A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma | ||
| NCT02329847 | A Study to Evaluate Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of the Combination of Ibrutinib With Nivolumab in Participants With Hematologic Malignancies | ||
| NCT01973049 | UNITY 2: A Study of an Investigational Treatment Regimen of DCV+ASV+BMS-791325 in a Fixed Dose Combination (the DCV 3DAA (Direct Acting Antiviral) Regimen) With or Without RBV for 12 Weeks for the Treatment of Chronic Hepatitis C Virus(HCV)Genotype 1 Infection in Subjects With Compensated Cirrhosis | ||
| NCT00317915 | Irbesartan in Type 2 Diabetes | ||
| NCT01611558 | Phase II Study of Ipilimumab Monotherapy in Recurrent Platinum-sensitive Ovarian Cancer | ||
| NCT05599685 | A Study of Nivolumab, Ipilimumab, and Chemotherapy in Participants With Non-small Cell Lung Cancer | ||
| NCT00357604 | Atazanavir and Ritonavir (ATV/RTV) and an Oral Contraceptive in Healthy Females | ||
| NCT02750514 | An Investigational Immuno-therapy Study to Test Combination Treatments in Patients With Advanced Non-Small Cell Lung Cancer | ||
| NCT00106808 | Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes | ||
| NCT01515202 | Japanese Phase 1 Multiple Ascending Dose Study | ||
| NCT01489059 | Safety Study of IL-21/Ipilimumab Combination in the Treatment of Melanoma | ||
| NCT01775631 | Combination Study of Urelumab and Rituximab in Patients With B-cell Non-Hodgkins Lymphoma | ||
| NCT03029780 | An Investigational Immuno-Therapy Safety and Efficacy Study of Multiple Administration Regimens for Nivolumab Plus Ipilimumab in Subjects With Renal Cell Carcinoma | ||
| NCT01581203 | Phase III Hallmark DUAL: ASV+DCV (Nulls/Partials, Intolerants/Ineligibles. Naives) | ||
| NCT04495296 | A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TST001 in Advanced or Metastatic Solid Tumors | ||
| NCT05407441 | Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def Tumors | ||
| NCT02598466 | Patient-Reported Efficacy of Subcutaneous (SC) Abatacept in Rheumatoid Arthritis (RA) - South Africa | ||
| NCT03366766 | Nivolumab Plus Cisplatin/Pemetrexed or Cisplatin/Gemcitabine as Induction in Resectable Non-Small Cell Lung Cancer | ||
| NCT00203931 | Trial Comparing Cetuximab With Pemetrexed/Cetuximab Therapy for Non-Small Cell Lung Cancer | ||
| NCT00002261 | A Comparative Phase I Clinical Study of HIVAC-1e and Smallpox (Vaccinia) Vaccines in Previously (Vaccinia) Vaccinated and Unvaccinated Volunteers |
